✅ NHS-sourced information. General health information only — not personal medical advice. Always consult your GP or specialist.

NICE Cancer 09 September 2026

Durvalumab with platinum-based chemotherapy, then with or without olaparib, for untreated advanced or recurrent endometrial cancer

TA1190

New Guidance: NICE
View official guidance ↗

TA1190

📋 What this means for you: Speak to your GP or specialist to understand how this guidance affects your care.

This article summarises content originally published by NICE. PatientIQ provides independent plain English summaries.

Free health updates

Stay one step ahead
of your condition.

New trial alerts, treatment news, and plain-English updates — matched to your condition. Free forever.

No spam. Unsubscribe anytime. Your data is private.